# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(...
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(...
Craig-Hallum analyst Matt Hewitt downgrades Champions Oncology (NASDAQ:CSBR) from Buy to Hold.
Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of ...